17Dec 2022
High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial

High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial

When compared with VenturiMask after extubation, high-flow nasal oxygen provides physiological advantages. To establish whether high-flow oxygen prevents endotracheal reintubation in hypoxemic patients after extubation, compared with VenturiMask. In this multicenter randomized trial, 494 patients exhibiting PaO2:FiO2 ratio ⩽ 300 mm Hg after extubation were randomly assigned to receive high-flow or VenturiMask oxygen, with the possibility to apply noninvasive rescue ventilation before reintubation. High-flow use in the VenturiMask group was not permitted. The Reintubation rate did not significantly differ between patients treated with VenturiMask or high-flow oxygen after extubation. However, high-flow oxygen yielded less frequent use of noninvasive rescue ventilation.

  • #critical care

Like

Save

Share